COMMUNIQUÉS West-GlobeNewswire

LogicBio Therapeutics Expands Leadership Team and Bolsters Capabilities to Support GeneRide™ Platform Development and Advancement of Lead Program into Clinic
22/04/2019
Company’s move into new facilities triples lab space CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably [...]
Adynxx Announces Merger Agreement with Alliqua BioMedical and Provides Business and Clinical Update
22/04/2019
Adynxx announced plans to merge with Alliqua BioMedical and become a Nasdaq-listed public company in early 2019 Company announced receipt of substantial grant award from the National Institute on Drug Abuse to support [...]
Molecular Templates Announces FDA Acceptance of IND Application for MT-5111, An Engineered Toxin Body Targeting HER2
22/04/2019
Dosing in Phase I Study in Patients with HER2-Positive Cancers Expected to Start in 3Q19 AUSTIN, Texas, April 22, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) a clinical stage biopharmaceutical [...]
Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback
22/04/2019
EMERYVILLE, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), an immuno-oncology company developing tumor-specific cancer immunotherapies to fight multiple cancer types, today announced [...]
Tabula Rasa HealthCare Continues Growth Trajectory by Expanding Integrated Services in PACE
22/04/2019
Subsidiary companies now support all aspects of PACE health plan management MOORESTOWN, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a leading provider of technology- [...]
Axogen, Inc. Announces Completion of Planned Interim Analysis and One-Time Enrollment Expansion for RECON® Study
22/04/2019
Company to Expand Enrollment by 50 Subjects to Support Planned Power of the Study ALACHUA, Fla., April 22, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative [...]
Axogen, Inc. to Report First Quarter 2019 Financial Results and Host Conference Call on May 8, 2019
22/04/2019
ALACHUA, Fla., April 22, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced [...]
ProQR to Present at Three Scientific Conferences in April
22/04/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Poseida Therapeutics Raises $142 Million in Series C Financing
22/04/2019
SAN DIEGO, April 22, 2019 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, [...]
Tonix Pharmaceuticals Announces that Breakthrough Therapy Designation Remains in Effect for Tonmya® for the Treatment of Posttraumatic Stress Disorder
22/04/2019
Company Will Meet with FDA in June to Address the “Intent to Rescind” Notice NEW YORK, April 22, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage [...]
Arrayit Corporation Nationwide Allergy Testing Services Network Surges to 700 Clinics
22/04/2019
Sunnyvale, April 22, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that its national network of allergy testing services clinics has nearly [...]
TLC to Present at Upcoming Conferences
22/04/2019
SOUTH SAN FRANCISCO, CA and TAIPEI, Taiwan, April 22, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel [...]
Jour de la Terre Une meilleure santé grâce aux espaces verts
22/04/2019
MONTRÉAL, 22 avr. 2019 (GLOBE NEWSWIRE) -- Dans le cadre du Jour de la Terre , la Fondation de l’Institut de Cardiologie de Montréal fait le point sur les effets des espaces verts sur la santé, et leur rôle dans la [...]
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19/04/2019
BOTHELL, Wash., April 19, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Geocann Introduces Patent-Protected VESIsorb® Formulated Cannabis Products to the Global Marketplace
19/04/2019
Natural products industry veteran launches cannabis company powered by an intellectual property portfolio with a successful track record of global distribution and a growing body of supporting science. FORT COLLINS, [...]
GUERBET : Mise à disposition du Document de Référence 2018
19/04/2019
Mise à disposition du Document de Référence 2018 Villepinte, le 19 avril 2019 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, a déposé son Document de [...]
Coherus BioSciences Announces New Employment Inducement Grants
19/04/2019
REDWOOD CITY, Calif., April 19, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective April 18, 2019, the compensation committee of the company’s board of directors granted [...]
Eidos Therapeutics to Present at Two Upcoming Investor Conferences
19/04/2019
SAN FRANCISCO, April 19, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management will present at two upcoming investor conferences. Class of 2018 Biotech IPOs Investor Day [...]
Constellation Pharmaceuticals to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day
19/04/2019
CAMBRIDGE, Mass., April 19, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]

Pages